Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Completed 5Recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

NET 5Gastrointestinal 5Endocrine 5

Conditions

Neuroendocrine Tumors 208Carcinoid Tumor 26Neoplasms 22Pancreatic Neoplasms 16Gastro-enteropancreatic neuroendocrine tumor 14Carcinoma, Neuroendocrine 11Carcinoma 11Adenoma, Islet Cell 11Neoplasm Metastasis 10Colorectal Neoplasms 9Lung Neoplasms 8Serotonin Syndrome 7Prostatic Neoplasms 7Adenocarcinoma 7Pheochromocytoma 6Gastrointestinal Neoplasms 6Colonic Neoplasms 6Breast Neoplasms 6Thyroid Neoplasms 5Stomach Neoplasms 5Somatostatinoma 5Neuroblastoma 5Melanoma 5Gastroenteropancreatic Neuroendocrine Tumors 5Cholangiocarcinoma 5Carcinoma, Renal Cell 5Vipoma 4Sarcoma 4Rectal Neoplasms 4Paraganglioma 4

Interventions

Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Gastroenteropancreatic Neuroendocrine Tumors × NET × Clear all
NCT02608203 2022-10-14

GEP-NOC

Assistance Publique Hopitaux De Marseille

Phase 2/3 Completed
18 enrolled
EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02630654 2021-12-07

EXPLAIN

Ipsen

Completed
404 enrolled
EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02730104 2020-06-26

Community-based Neuroendocrine Tumor (NET) Research Study

Ipsen

Completed
100 enrolled
EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02162446 2019-10-02

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Ipsen

Phase 1/2 Completed
12 enrolled 11 charts
EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02231762 2019-05-06

SONNET

Ipsen

Phase 2 Completed
57 enrolled 20 charts
EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡